Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
about
The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicineAbnormalities in the regulators of angiogenesis in patients with sclerodermaMolecular pathogenesis of skin fibrosis: insight from animal models.Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma.Hepatocyte Growth Factor Gene-Modified Mesenchymal Stem Cells Augment Sinonasal Wound HealingCellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective.Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gammaUrokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.PAI-1 in tissue fibrosis.The growth factors involved in flexor tendon repair and adhesion formation.Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice.Wenyang Huazhuo Tongluo formula inhibits fibrosis via suppressing Wnt/β-catenin signaling pathway in a Bleomycin-induced systemic sclerosis mouse model.
P2860
Q24609298-49279142-1595-4B05-BF75-1D3BD4FBA1F1Q33606645-90040DD8-E325-48EF-89DB-819CA04F24E4Q33819183-B75EC187-B069-4B81-89DD-E6046C460C90Q35630012-5099F0BC-863D-410A-8C3E-DDDD7DB9B87CQ35866057-3819E8B7-2E8E-4F13-A9C7-4DD76F77ED7FQ36023633-AD03F1EA-FAF7-4192-BC8C-8529C50011A2Q37071874-E3470308-C5D2-438D-8622-04536DC26801Q37460349-AD2D1EBE-E55B-4F8B-A775-66B5DDF991BBQ37861626-DF03A393-E9AB-417A-9AD2-045A0BAFF331Q38155762-2FAA1072-D4C5-4433-B2C8-C2408BE5921EQ42799009-E2751C12-C303-4F34-B065-90966F12B739Q45874899-52B4037A-052C-4605-A634-C8585DF4C67EQ54093499-7087F025-8E09-412F-AFA1-D37716CFB6B9
P2860
Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Hepatocyte growth factor both ...... a mouse model of scleroderma.
@en
Hepatocyte growth factor both ...... a mouse model of scleroderma.
@nl
type
label
Hepatocyte growth factor both ...... a mouse model of scleroderma.
@en
Hepatocyte growth factor both ...... a mouse model of scleroderma.
@nl
prefLabel
Hepatocyte growth factor both ...... a mouse model of scleroderma.
@en
Hepatocyte growth factor both ...... a mouse model of scleroderma.
@nl
P2093
P2860
P356
P1433
P1476
Hepatocyte growth factor both ...... a mouse model of scleroderma.
@en
P2093
Katayama I
Nishioka K
Takagawa S
Yamamoto T
Yokozeki H
P2860
P2888
P304
P356
10.1038/SJ.GT.3302165
P577
2004-01-01T00:00:00Z
P5875
P6179
1000339287